These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 33986133)
1. Clarence J. Gibbs Effect and the "Creutzfeldt-Jakob Disease" Eponym. Lanska DJ Neurology; 2021 Jul; 97(4):181-187. PubMed ID: 33986133 [TBL] [Abstract][Full Text] [Related]
2. Prion diseases with a focus on Creutzfeldt-Jakob disease, a summary of the incidence of Creutzfeldt-Jakob disease in the Czech Republic over the last 17 years, 2000-2017. Kolářová K; Marešová M; Manďáková Z; Kynčl J Epidemiol Mikrobiol Imunol; 2018; 67(4):155-160. PubMed ID: 30630318 [TBL] [Abstract][Full Text] [Related]
3. Serial EEG findings in sporadic and iatrogenic Creutzfeldt-Jakob disease. Wieser HG; Schwarz U; Blättler T; Bernoulli C; Sitzler M; Stoeck K; Glatzel M Clin Neurophysiol; 2004 Nov; 115(11):2467-78. PubMed ID: 15465434 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of Korean patients with suspected Creutzfeldt-Jakob disease with 14-3-3 protein in cerebrospinal fluid: Preliminary study of the Korean Creutzfeldt-Jakob disease active surveillance program. Lim JS; Kwon HM; Jang JW; Ju YR; Kim S; Park YH; Park SY; Kim S Prion; 2015; 9(2):136-43. PubMed ID: 25996401 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review. Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282 [TBL] [Abstract][Full Text] [Related]
7. Thinking the unthinkable: Alzheimer's, Creutzfeldt-Jakob and Mad Cow disease: the age-related reemergence of virulent, foodborne, bovine tuberculosis or losing your mind for the sake of a shake or burger. Broxmeyer L Med Hypotheses; 2005; 64(4):699-705. PubMed ID: 15694685 [TBL] [Abstract][Full Text] [Related]
8. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease. Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604 [TBL] [Abstract][Full Text] [Related]
9. Creutzfeldt-Jakob disease associated with a V203I homozygous mutation in the prion protein gene. Komatsu J; Sakai K; Hamaguchi T; Sugiyama Y; Iwasa K; Yamada M Prion; 2014; 8(5):336-8. PubMed ID: 25495585 [TBL] [Abstract][Full Text] [Related]
10. Review: Laboratory diagnosis and surveillance of Creutzfeldt-Jakob disease. Lee J; Hyeon JW; Kim SY; Hwang KJ; Ju YR; Ryou C J Med Virol; 2015 Jan; 87(1):175-86. PubMed ID: 24978677 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of IL-1β Signaling Normalizes NMDA-Dependent Neurotransmission and Reduces Seizure Susceptibility in a Mouse Model of Creutzfeldt-Jakob Disease. Bertani I; Iori V; Trusel M; Maroso M; Foray C; Mantovani S; Tonini R; Vezzani A; Chiesa R J Neurosci; 2017 Oct; 37(43):10278-10289. PubMed ID: 28924012 [TBL] [Abstract][Full Text] [Related]
12. [Human prion diseases: the Hungarian experience]. Kovács GG; Bakos A; Mitrova E; Minárovits J; László L; Majtényi K Ideggyogy Sz; 2007 Nov; 60(11-12):447-52. PubMed ID: 18200749 [TBL] [Abstract][Full Text] [Related]
13. Neuropathological findings in new variant CJD and experimental transmission of BSE. Ironside JW FEMS Immunol Med Microbiol; 1998 Jun; 21(2):91-5. PubMed ID: 9684997 [TBL] [Abstract][Full Text] [Related]
14. The impact of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease on plasma safety. Hoots WK; Abrams C; Tankersleydagger D Transfus Med Rev; 2001 Apr; 15(2 Suppl 1):45-59. PubMed ID: 11441420 [TBL] [Abstract][Full Text] [Related]
15. A Case of Creutzfeldt-Jakob Disease with Stroke-Like Onset. Okamoto K; Abe T; Itoh Y J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104788. PubMed ID: 32234269 [TBL] [Abstract][Full Text] [Related]
19. Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type 2. Samman I; Schulz-Schaeffer WJ; Wöhrle JC; Sommer A; Kretzschmar HA; Hennerici M J Neurol Neurosurg Psychiatry; 1999 Nov; 67(5):678-81. PubMed ID: 10519881 [TBL] [Abstract][Full Text] [Related]